MiniMed director granted 13,889 RSUs

MiniMed Group, Inc. director D Keith Grossman reported an equity compensation grant of 13,889 shares of Common Stock on March 9, 2026.

Rhea-AI Filing Summary

MiniMed Group, Inc. director D Keith Grossman reported an equity compensation grant of 13,889 shares of Common Stock on March 9, 2026. The award consists of restricted stock units that vest on the one-year anniversary of the grant date and were granted at no cash cost to him.

Following this grant, Grossman holds 13,889 shares of Common Stock directly, including shares that will be issued upon vesting of one or more restricted stock units. This filing reflects a compensation-related acquisition rather than an open-market stock purchase.

Insider Trade Summary

Grant/Award: 13,889 shares

Grant/Award 1 txn

Insider GROSSMAN D KEITH

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,889	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,889 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units that vest on the one-year anniversary of the grant date.
2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MiniMed Group (MMED) director D Keith Grossman report?

D Keith Grossman reported receiving 13,889 shares of MiniMed Group Common Stock as an equity compensation grant. The award is structured as restricted stock units, granted at no cash cost, and reflects a compensation-related acquisition rather than an open-market stock purchase or sale.

How many MiniMed Group (MMED) shares were granted to director D Keith Grossman?

Grossman was granted 13,889 shares of MiniMed Group Common Stock in the form of restricted stock units. These units represent future share delivery, subject to vesting, and bring his reported direct holdings to 13,889 shares following the transaction disclosed in the Form 4 filing.

When do D Keith Grossman’s MiniMed Group (MMED) restricted stock units vest?

The restricted stock units granted to Grossman vest on the one-year anniversary of the grant date. This means the 13,889 units convert into deliverable Common Stock after one year, aligning director compensation with ongoing service and the company’s long-term performance.

Was D Keith Grossman’s MiniMed Group (MMED) transaction an open-market stock purchase?

No, the transaction was not an open-market purchase. It was a grant of 13,889 restricted stock units at a stated price of $0.00 per share, reflecting equity compensation rather than Grossman using personal funds to buy MiniMed Group stock in the market.

What are D Keith Grossman’s MiniMed Group (MMED) holdings after this Form 4 transaction?

After the transaction, Grossman is reported as directly holding 13,889 shares of MiniMed Group Common Stock. This total includes shares that will be issued in connection with the vesting of one or more restricted stock units granted as part of his director compensation.

What does the $0.00 price on D Keith Grossman’s MiniMed Group (MMED) grant indicate?

The $0.00 price indicates the 13,889 restricted stock units were granted as compensation, not purchased with cash. Grossman does not pay an exercise or purchase price for these shares; instead, they vest over time based on the one-year vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROSSMAN D KEITH

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		A		13,889(1)	A	$0	13,889(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest on the one-year anniversary of the grant date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.